Expanding Access to Neurorehabilitation: NeuroAiDโขII Launches in Mongolia
Expanding Access to Neurorehabilitation: NeuroAiDโขII Launches in Mongolia Moleac is thrilled to announce the successful launch of NeuroAiDโขII in Mongolia!ย A significant milestone in our ambition to make NeuroAiDโขIIย available to more patients every year. We are proud...
Driving Collaboration in Brain Injury Care: Neurovascular Summit Highlights from Taipei
Driving Collaboration in Brain Injury Care: Neurovascular Summit Highlights from Taipei This past weekend, PT Ferron Par Pharmaceuticals, in collaboration with Moleac, hosted a Neurovascular Summit in Taipei, focusing on brain injury management. The meeting brought...
Unlocking Recovery Potential: Join Our ESOC 2026 Symposium on Post-Stroke Neurorehabilitation
Unlocking Recovery Potential: Join Our ESOC 2026 Symposium on Post-Stroke Neurorehabilitation Join us at European Stroke Organisation Conference (ESOC) in Maastricht for our symposium on ๐จ๐ป๐น๐ผ๐ฐ๐ธ๐ถ๐ป๐ด ๐ฅ๐ฒ๐ฐ๐ผ๐๐ฒ๐ฟ๐ ๐ฃ๐ผ๐๐ฒ๐ป๐๐ถ๐ฎ๐น: ๐๐ฑ๐๐ฎ๐ป๐ฐ๐ฒ๐ ๐ถ๐ป ๐ฃ๐ผ๐๐-๐ฆ๐๐ฟ๐ผ๐ธ๐ฒ ๐ก๐ฒ๐๐ฟ๐ผ๐ฟ๐ฒ๐ต๐ฎ๐ฏ๐ถ๐น๐ถ๐๐ฎ๐๐ถ๐ผ๐ป. Save...
Can Homocysteine Track Alzheimerโs Progression? New Insights into a Promising Biomarker
Can Homocysteine Track Alzheimerโs Progression? New Insights into a Promising Biomarker ๐ฐ๐ง ๐ฌ ALZHEIMERโS DISEASE STUDY HIGHLIGHTS – Serum Homocysteine as a Potential Dynamic Biomarker for Staging and Monitoring Progression in Alzheimerโs Disease by Wu C, et al....
